Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer’s Disease and Related Disorders
<p dir="ltr">The field of Alzheimer’s disease (AD) has witnessed recent breakthroughs in the development of disease-modifying biologics and diagnostic markers. While immunotherapeutic interventions have provided much-awaited solutions, nucleic acid-based tools represent other avenues...
Saved in:
| Main Author: | Jaunetta Hill (18255631) (author) |
|---|---|
| Other Authors: | Karim E. Shalaby (12267224) (author), Syed W. Bihaqi (19457386) (author), Bothaina H. Alansi (19457389) (author), Benjamin Barlock (13119613) (author), Keykavous Parang (281303) (author), Richard Thompson (47003) (author), Khalid Ouararhni (3145734) (author), Nasser H. Zawia (18255646) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation study
by: Jonas Ellegaard Nielsen (21633062)
Published: (2024) -
Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions
by: Sama Ayoub (15430987)
Published: (2025) -
Leveraging hallmark Alzheimer’s molecular targets using phytoconstituents: Current perspective and emerging trends
by: Prajakta A. Dhage (17302789)
Published: (2021) -
A new method to improve the lifetime stability of small molecule bilayer heterojunction organic solar cells
by: AL-Amar, Mohammad M.
Published: (2013) -
An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy
by: Nimshitha Pavathuparambil Abdul Manaph (17870420)
Published: (2019)